Research Article

Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus

Table 2

Results of laboratory tests before and 1 week after procedure.

Laboratory testBefore procedure1 week after procedure value

TB (μmol/L)14.0 ± 4.516.3 ± 7.20.427
ALB (g/L)37.5 ± 9.439.2 ± 5.10.612
ALT (U/L)50.9 ± 25.841.8 ± 21.60.001
AST (U/L)57.6 ± 19.944.2 ± 26.10.001
CR (μmol/L)75.3 ± 15.371.9 ± 10.20.329
PT (s)11.9 ± 2.414.2 ± 3.20.149
WBC (109/L)6.1 ± 2.65.3 ± 1.80.347
PLT (109/L)143.6 ± 64.6151.0 ± 82.30.378

ALB = albumin; ALT = alanine transaminase; AST = aspartate transaminase; CR = creatinine; CTCAE = Common Toxicity Criteria for Adverse Events; PLT = platelets; PT = prothrombin time; TB = total bilirubin. Data expressed as mean ± SD.